Gefitinib for epidermal growth factor receptor mutant lung cancers: searching for a weapon of mass destruction
- PMID: 16785470
- DOI: 10.1200/JCO.2006.06.6555
Gefitinib for epidermal growth factor receptor mutant lung cancers: searching for a weapon of mass destruction
Comment on
-
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.J Clin Oncol. 2006 Jul 20;24(21):3340-6. doi: 10.1200/JCO.2005.05.4692. Epub 2006 Jun 19. J Clin Oncol. 2006. PMID: 16785471 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials